Glucuronolactone Market Outlook

The glucuronolactone market size is projected to be valued at US$ 120 million in 2023 and is expected to rise to US$ 256.2 million by 2033. The sales of glucuronolactone are expected to thrive at a significant CAGR of 8.0% during the forecast period.

Glucuronolactone is used as a food additive in food and functional beverages. In terms of purity, 0.99% grade of glucuronolactone is highly preferable among manufacturers. Also, increasing consumption of energy drinks is one of the key factors fueling the demand for Glucuronolactone in the market.

Glucuronolactone is an odorless, white solid substance found in people, animals, and the gums of plants. It is a vital component of all linked tissues. It is a chemical created by the human liver's glucose metabolism. Glucuronolactone is a component of connective tissues as well as an important antioxidant in the production of ascorbic acid.

Given its numerous health benefits, the increasing adoption of glucuronolactone from various end-use industries such as pharmaceuticals and food and beverages is a significant factor contributing to the growth glucuronolactone market. Some factors expected to drive the glucuronolactone market further during the forecast period include:

  • Increased use of glucuronolactone as an ingredient in functional foods and energy drinks to act as a potent antioxidant.
  • Eliminate harmful chemicals through waste from the body, fueled by increased consumer health awareness.
Attributes Details
Glucuronolactone Market Estimated Size (2023) US$ 120 million
Glucuronolactone Market CAGR (2023 to 2033) 8.0%
Glucuronolactone Market Forecasted Size (2033) US$ 256.2 million

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Glucuronolactone Market Historic and Future Outlook Comparison

Glucuronolactone sales expanded at a CAGR of 5.4% between 2018 and 2022. The period marked the entry of various market players and product innovations.

In pharmaceuticals, glucuronolactone is frequently used as a component in the production of a range of treatment options for food and drug poisoning, hepatitis, and immune response modulation. Further, a rise in demand from bodybuilders and athletes is also expected to contribute to market expansion.

High glucuronolactone prices, as well as various negative impacts related to excessive glucuronolactone intakes, such as dizziness, disorientation, and fast heartbeat, are anticipated to hamper the market growth during the forecast period.

Glucuronolactone-based Dietary Supplements are Becoming Popular

The human brain, liver, and heart contain glucuronolactone, which is involved in a range of physiological functions. Some of its metabolic roles include osmoregulation, membrane stability, and bile acid conjugation. Further, cardiovascular disease, retinal degeneration, and epilepsy are all diseases that can be caused by glucuronolactone shortage.

Glucuronolactone supplementation has been demonstrated to be beneficial to one's health. This indeed is increasing the demand for dietary supplements around the world as people grow concerned about their health. Furthermore, this has increased demand for glucuronolactone containing supplements, resulting in market expansion.

The rise in demand from the pharmaceutical and food & beverage industries, as well as increased awareness about a healthy lifestyle, are two key factors driving the glucuronolactone market.

Nandini Roy Choudhury
Nandini Roy Choudhury

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Category-wise Insights

Glucuronolactone Application in Pharmaceuticals is Accounting for a Prominent Share

The pharmaceutical application is estimated to rise at a signifcant rate, with a CAGR of 7.0% from 2023 to 2033, as a result of the increased application of glucuronolactone-based pills and supplements to treat hepatocirrhosis, arthritis, and hepatitis, Furthermore, the market growth is likely to be fueled by the recovery of the pharmaceutical industry in the United States over the forecast period.

Powder Form of Glucuronolactone is Accounting for a Significant Share

The powder form of glucuronolactone is projected to account for a significant share as consumers are consuming it as a dietary supplement over the projection period. Additionally, a growing health conscious population in the urban area is expected to boost demand growth for powder glucuronolactone.

Regional Analysis of the Glucuronolactone Market

Sales of Glucuronolactone in the United States

The United States accounted for 25.7% of the total market in 2022 in North America and is expected to rise significantly due to the widespread use of glucuronolactone as a nutritional supplement in the country. Additionally, glucuronolactone-containing drinks have been popular in the country.

Companies like Rockstar Inc., Red Bull, and Monster have released numerous glucuronolactone-containing drinks, which might offer enormous potential throughout the projected period. However, due to restrictions on the use of glucuronolactone in traditional beverages, the majority of these drinks are sold as supplements.

Consumption of Glucuronolactone in the United Kingdom

The use of glucuronolactone in prescription medications for the treatment of collagen disease, hepatitis, and bone illnesses in the United Kingdom, and Europe is predicted to increase at a CAGR of 3.0% from 2023 to 2033. In addition, government backing, together with increased research and development expenditure, is predicted to contribute significantly to market growth.

Rising Demand for Glucuronolactone in China

The high number of glucuronolactone producers in China and the high level of exports are expected to increase at a CAGR of 5.8% from 2023 to 2033. Furthermore, the product's widespread availability in China is projected to benefit the market in the approaching years. Also, the pharmaceutical industry in China, India, Indonesia, Malaysia, the Philippines, Singapore, Thailand, and Vietnam is expanding.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Market Competition

Some of the key players operating in the glucuronolactone market are Shaoxing Marina Biotechnology Co.Ltd., Hubei Yitai Pharmaceutical Co.Ltd., Anhui Fubore Pharmaceutical & Chemical Co.Ltd., Functional Food chem International Corporation, Merck Millipore Corporation, Jungbunzlauer, Shandong Fuyuan Bio-Tech CO.LTD, Roquette Frères, Shandong Xinhong Pharmaceutical Co., Ltd., Shandong Baisheng Biotechnology Co., Ltd., and others.

  • Hubei Yitai Pharmaceutical Co., Ltd provides glucuronolactone, which is commonly used as a food ingredient in health foods and functional beverages. The product control’s immunological function, anti-aging, moistens skin, improves oxygen to the brain, and aids in tiredness recovery.
  • Red Bull Energy Drink is one of the leading end-users, selling its products in over 169 countries and selling roughly 6 billion cans every year. Red Bull's primary markets are the United States and Western Europe.

Scope of the Report

Attributes Details
Growth Rate CAGR of 8.0% from 2023 to 2033
Base Year of Estimation 2022
Historical Data 2018 to 2022
Forecast Period 2023 to 2033
Quantitative Units Revenue in US$ million and Volume in Units and F-CAGR from 2023 to 2033
Report Coverage Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, growth factors, Trends and Pricing Analysis
Key Segments Covered By Form, By End User, By Region
Regions Covered North America; Latin America; Europe; East Asia; South Asia; The Middle East & Africa; Oceania
Key Countries Profiled The United States, Canada, Brazil, Mexico, Germany, Italy, France, The United Kingdom, Spain, Russia, China, Japan, India, GCC Countries, Australia
Key Companies Profiled Shaoxing Marina Biotechnology Co.Ltd.; Hubei Yitai Pharmaceutical Co.Ltd.; Merck Millipore Corporation; Anhui Fubore Pharmaceutical & Chemical Co.Ltd.; Functional Food chem International Corporation; Jungbunzlauer; Shandong Fuyuan Bio-Tech CO.LTD.; Roquette Frères; Shandong Xinhong Pharmaceutical Co., Ltd.; Shandong Baisheng Biotechnology Co., Ltd.; Ceto Coorporation; Creative Compound; Foodchem International; Merck Millipore
Customization & Pricing Available upon Request

Key Segments Covered in the Glucuronolactone Market Report

By Form:

  • Powder
  • Liquid
  • Tablet & Capsules

By End Use:

  • Dietary Supplement
  • Energy Drinks
  • Pharmaceuticals
  • Cosmetics
  • Functional Food

By Region:

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • Asia Pacific excluding Japan (APEJ)
  • Japan
  • The Middle East & Africa (MEA)

Frequently Asked Questions

What is the Glucuronolactone Market Size in 2023? 

The market is valued at US$ 120.0 million in 2023. 

Who are the Prominent Market Players? 

Jungbunzlauer, and Roquette Frères are the prominent market players. 

What is the Projected Market Size in 2033? 

The market is likely to reach US$ 256.2 million by 2033. 

What Drives the Sales of the Market? 

Rising awareness about a healthy lifestyle drives sales.

How is the historical performance of the Market? 

The market registered a CAGR of 5.4% from 2018 to 2022.

Table of Content
1. Executive Summary
    1.1. Global Market Outlook
    1.2. Demand-side Trends
    1.3. Supply-side Trends
    1.4. Technology Roadmap Analysis
    1.5. Analysis and Recommendations
2. Market Overview
    2.1. Market Coverage / Taxonomy
    2.2. Market Definition / Scope / Limitations
3. Market Background
    3.1. Market Dynamics
        3.1.1. Drivers
        3.1.2. Restraints
        3.1.3. Opportunity
        3.1.4. Trends
    3.2. Scenario Forecast
        3.2.1. Demand in Optimistic Scenario
        3.2.2. Demand in Likely Scenario
        3.2.3. Demand in Conservative Scenario
    3.3. Opportunity Map Analysis
    3.4. Product Life Cycle Analysis
    3.5. Supply Chain Analysis
        3.5.1. Supply Side Participants and their Roles
            3.5.1.1. Producers
            3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers)
            3.5.1.3. Wholesalers and Distributors
        3.5.2. Value Added and Value Created at Node in the Supply Chain
        3.5.3. List of Raw Material Suppliers
        3.5.4. List of Existing and Potential Buyer’s
    3.6. Investment Feasibility Matrix
    3.7. Value Chain Analysis
        3.7.1. Profit Margin Analysis
        3.7.2. Wholesalers and Distributors
        3.7.3. Retailers
    3.8. PESTLE and Porter’s Analysis
    3.9. Regulatory Landscape
        3.9.1. By Key Regions
        3.9.2. By Key Countries
    3.10. Regional Parent Market Outlook
    3.11. Production and Consumption Statistics
    3.12. Import and Export Statistics
4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033
    4.1. Historical Market Size Value (US$ Million) & Volume (MT) Analysis, 2018 to 2022
    4.2. Current and Future Market Size Value (US$ Million) & Volume (MT) Projections, 2023 to 2033
        4.2.1. Y-o-Y Growth Trend Analysis
        4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Form
    5.1. Introduction / Key Findings
    5.2. Historical Market Size Value (US$ Million) & Volume (MT) Analysis By Form, 2018 to 2022
    5.3. Current and Future Market Size Value (US$ Million) & Volume (MT) Analysis and Forecast By Form, 2023 to 2033
        5.3.1. Powder
        5.3.2. Liquid
        5.3.3. Tablet & Capsules
    5.4. Y-o-Y Growth Trend Analysis By Form, 2018 to 2022
    5.5. Absolute $ Opportunity Analysis By Form, 2023 to 2033
6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End Use
    6.1. Introduction / Key Findings
    6.2. Historical Market Size Value (US$ Million) & Volume (MT) Analysis By End Use, 2018 to 2022
    6.3. Current and Future Market Size Value (US$ Million) & Volume (MT) Analysis and Forecast By End Use, 2023 to 2033
        6.3.1. Dietary Supplement
        6.3.2. Energy Drinks
        6.3.3. Pharmaceuticals
        6.3.4. Cosmetics
        6.3.5. Functional Food
    6.4. Y-o-Y Growth Trend Analysis By End Use, 2018 to 2022
    6.5. Absolute $ Opportunity Analysis By End Use, 2023 to 2033
7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region
    7.1. Introduction
    7.2. Historical Market Size Value (US$ Million) & Volume (MT) Analysis By Region, 2018 to 2022
    7.3. Current Market Size Value (US$ Million) & Volume (MT) Analysis and Forecast By Region, 2023 to 2033
        7.3.1. North America
        7.3.2. Latin America
        7.3.3. Western Europe
        7.3.4. Eastern Europe
        7.3.5. South Asia and Pacific
        7.3.6. East Asia
        7.3.7. Middle East and Africa
    7.4. Market Attractiveness Analysis By Region
8. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
    8.1. Historical Market Size Value (US$ Million) & Volume (MT) Trend Analysis By Market Taxonomy, 2018 to 2022
    8.2. Market Size Value (US$ Million) & Volume (MT) Forecast By Market Taxonomy, 2023 to 2033
        8.2.1. By Country
            8.2.1.1. USA
            8.2.1.2. Canada
        8.2.2. By Form
        8.2.3. By End Use
    8.3. Market Attractiveness Analysis
        8.3.1. By Country
        8.3.2. By Form
        8.3.3. By End Use
    8.4. Key Takeaways
9. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
    9.1. Historical Market Size Value (US$ Million) & Volume (MT) Trend Analysis By Market Taxonomy, 2018 to 2022
    9.2. Market Size Value (US$ Million) & Volume (MT) Forecast By Market Taxonomy, 2023 to 2033
        9.2.1. By Country
            9.2.1.1. Brazil
            9.2.1.2. Mexico
            9.2.1.3. Rest of Latin America
        9.2.2. By Form
        9.2.3. By End Use
    9.3. Market Attractiveness Analysis
        9.3.1. By Country
        9.3.2. By Form
        9.3.3. By End Use
    9.4. Key Takeaways
10. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
    10.1. Historical Market Size Value (US$ Million) & Volume (MT) Trend Analysis By Market Taxonomy, 2018 to 2022
    10.2. Market Size Value (US$ Million) & Volume (MT) Forecast By Market Taxonomy, 2023 to 2033
        10.2.1. By Country
            10.2.1.1. Germany
            10.2.1.2. UK
            10.2.1.3. France
            10.2.1.4. Spain
            10.2.1.5. Italy
            10.2.1.6. Rest of Western Europe
        10.2.2. By Form
        10.2.3. By End Use
    10.3. Market Attractiveness Analysis
        10.3.1. By Country
        10.3.2. By Form
        10.3.3. By End Use
    10.4. Key Takeaways
11. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
    11.1. Historical Market Size Value (US$ Million) & Volume (MT) Trend Analysis By Market Taxonomy, 2018 to 2022
    11.2. Market Size Value (US$ Million) & Volume (MT) Forecast By Market Taxonomy, 2023 to 2033
        11.2.1. By Country
            11.2.1.1. Poland
            11.2.1.2. Russia
            11.2.1.3. Czech Republic
            11.2.1.4. Romania
            11.2.1.5. Rest of Eastern Europe
        11.2.2. By Form
        11.2.3. By End Use
    11.3. Market Attractiveness Analysis
        11.3.1. By Country
        11.3.2. By Form
        11.3.3. By End Use
    11.4. Key Takeaways
12. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
    12.1. Historical Market Size Value (US$ Million) & Volume (MT) Trend Analysis By Market Taxonomy, 2018 to 2022
    12.2. Market Size Value (US$ Million) & Volume (MT) Forecast By Market Taxonomy, 2023 to 2033
        12.2.1. By Country
            12.2.1.1. India
            12.2.1.2. Bangladesh
            12.2.1.3. Australia
            12.2.1.4. New Zealand
            12.2.1.5. Rest of South Asia and Pacific
        12.2.2. By Form
        12.2.3. By End Use
    12.3. Market Attractiveness Analysis
        12.3.1. By Country
        12.3.2. By Form
        12.3.3. By End Use
    12.4. Key Takeaways
13. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
    13.1. Historical Market Size Value (US$ Million) & Volume (MT) Trend Analysis By Market Taxonomy, 2018 to 2022
    13.2. Market Size Value (US$ Million) & Volume (MT) Forecast By Market Taxonomy, 2023 to 2033
        13.2.1. By Country
            13.2.1.1. China
            13.2.1.2. Japan
            13.2.1.3. South Korea
        13.2.2. By Form
        13.2.3. By End Use
    13.3. Market Attractiveness Analysis
        13.3.1. By Country
        13.3.2. By Form
        13.3.3. By End Use
    13.4. Key Takeaways
14. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
    14.1. Historical Market Size Value (US$ Million) & Volume (MT) Trend Analysis By Market Taxonomy, 2018 to 2022
    14.2. Market Size Value (US$ Million) & Volume (MT) Forecast By Market Taxonomy, 2023 to 2033
        14.2.1. By Country
            14.2.1.1. GCC Countries
            14.2.1.2. South Africa
            14.2.1.3. Israel
            14.2.1.4. Rest of MEA
        14.2.2. By Form
        14.2.3. By End Use
    14.3. Market Attractiveness Analysis
        14.3.1. By Country
        14.3.2. By Form
        14.3.3. By End Use
    14.4. Key Takeaways
15. Key Countries Market Analysis
    15.1. USA
        15.1.1. Pricing Analysis
        15.1.2. Market Share Analysis, 2022
            15.1.2.1. By Form
            15.1.2.2. By End Use
    15.2. Canada
        15.2.1. Pricing Analysis
        15.2.2. Market Share Analysis, 2022
            15.2.2.1. By Form
            15.2.2.2. By End Use
    15.3. Brazil
        15.3.1. Pricing Analysis
        15.3.2. Market Share Analysis, 2022
            15.3.2.1. By Form
            15.3.2.2. By End Use
    15.4. Mexico
        15.4.1. Pricing Analysis
        15.4.2. Market Share Analysis, 2022
            15.4.2.1. By Form
            15.4.2.2. By End Use
    15.5. Germany
        15.5.1. Pricing Analysis
        15.5.2. Market Share Analysis, 2022
            15.5.2.1. By Form
            15.5.2.2. By End Use
    15.6. UK
        15.6.1. Pricing Analysis
        15.6.2. Market Share Analysis, 2022
            15.6.2.1. By Form
            15.6.2.2. By End Use
    15.7. France
        15.7.1. Pricing Analysis
        15.7.2. Market Share Analysis, 2022
            15.7.2.1. By Form
            15.7.2.2. By End Use
    15.8. Spain
        15.8.1. Pricing Analysis
        15.8.2. Market Share Analysis, 2022
            15.8.2.1. By Form
            15.8.2.2. By End Use
    15.9. Italy
        15.9.1. Pricing Analysis
        15.9.2. Market Share Analysis, 2022
            15.9.2.1. By Form
            15.9.2.2. By End Use
    15.10. Poland
        15.10.1. Pricing Analysis
        15.10.2. Market Share Analysis, 2022
            15.10.2.1. By Form
            15.10.2.2. By End Use
    15.11. Russia
        15.11.1. Pricing Analysis
        15.11.2. Market Share Analysis, 2022
            15.11.2.1. By Form
            15.11.2.2. By End Use
    15.12. Czech Republic
        15.12.1. Pricing Analysis
        15.12.2. Market Share Analysis, 2022
            15.12.2.1. By Form
            15.12.2.2. By End Use
    15.13. Romania
        15.13.1. Pricing Analysis
        15.13.2. Market Share Analysis, 2022
            15.13.2.1. By Form
            15.13.2.2. By End Use
    15.14. India
        15.14.1. Pricing Analysis
        15.14.2. Market Share Analysis, 2022
            15.14.2.1. By Form
            15.14.2.2. By End Use
    15.15. Bangladesh
        15.15.1. Pricing Analysis
        15.15.2. Market Share Analysis, 2022
            15.15.2.1. By Form
            15.15.2.2. By End Use
    15.16. Australia
        15.16.1. Pricing Analysis
        15.16.2. Market Share Analysis, 2022
            15.16.2.1. By Form
            15.16.2.2. By End Use
    15.17. New Zealand
        15.17.1. Pricing Analysis
        15.17.2. Market Share Analysis, 2022
            15.17.2.1. By Form
            15.17.2.2. By End Use
    15.18. China
        15.18.1. Pricing Analysis
        15.18.2. Market Share Analysis, 2022
            15.18.2.1. By Form
            15.18.2.2. By End Use
    15.19. Japan
        15.19.1. Pricing Analysis
        15.19.2. Market Share Analysis, 2022
            15.19.2.1. By Form
            15.19.2.2. By End Use
    15.20. South Korea
        15.20.1. Pricing Analysis
        15.20.2. Market Share Analysis, 2022
            15.20.2.1. By Form
            15.20.2.2. By End Use
    15.21. GCC Countries
        15.21.1. Pricing Analysis
        15.21.2. Market Share Analysis, 2022
            15.21.2.1. By Form
            15.21.2.2. By End Use
    15.22. South Africa
        15.22.1. Pricing Analysis
        15.22.2. Market Share Analysis, 2022
            15.22.2.1. By Form
            15.22.2.2. By End Use
    15.23. Israel
        15.23.1. Pricing Analysis
        15.23.2. Market Share Analysis, 2022
            15.23.2.1. By Form
            15.23.2.2. By End Use
16. Market Structure Analysis
    16.1. Competition Dashboard
    16.2. Competition Benchmarking
    16.3. Market Share Analysis of Top Players
        16.3.1. By Regional
        16.3.2. By Form
        16.3.3. By End Use
17. Competition Analysis
    17.1. Competition Deep Dive
        17.1.1. Shaoxing Marina Biotechnology Co.Ltd.
            17.1.1.1. Overview
            17.1.1.2. Product Portfolio
            17.1.1.3. Profitability by Market Segments
            17.1.1.4. Sales Footprint
            17.1.1.5. Strategy Overview
                17.1.1.5.1. Marketing Strategy
                17.1.1.5.2. Product Strategy
                17.1.1.5.3. Channel Strategy
        17.1.2. Hubei Yitai Pharmaceutical Co.Ltd.
            17.1.2.1. Overview
            17.1.2.2. Product Portfolio
            17.1.2.3. Profitability by Market Segments
            17.1.2.4. Sales Footprint
            17.1.2.5. Strategy Overview
                17.1.2.5.1. Marketing Strategy
                17.1.2.5.2. Product Strategy
                17.1.2.5.3. Channel Strategy
        17.1.3. Merck Millipore Corporation
            17.1.3.1. Overview
            17.1.3.2. Product Portfolio
            17.1.3.3. Profitability by Market Segments
            17.1.3.4. Sales Footprint
            17.1.3.5. Strategy Overview
                17.1.3.5.1. Marketing Strategy
                17.1.3.5.2. Product Strategy
                17.1.3.5.3. Channel Strategy
        17.1.4. Anhui Fubore Pharmaceutical & Chemical Co.Ltd.
            17.1.4.1. Overview
            17.1.4.2. Product Portfolio
            17.1.4.3. Profitability by Market Segments
            17.1.4.4. Sales Footprint
            17.1.4.5. Strategy Overview
                17.1.4.5.1. Marketing Strategy
                17.1.4.5.2. Product Strategy
                17.1.4.5.3. Channel Strategy
        17.1.5. Functional Food chem International Corporation
            17.1.5.1. Overview
            17.1.5.2. Product Portfolio
            17.1.5.3. Profitability by Market Segments
            17.1.5.4. Sales Footprint
            17.1.5.5. Strategy Overview
                17.1.5.5.1. Marketing Strategy
                17.1.5.5.2. Product Strategy
                17.1.5.5.3. Channel Strategy
        17.1.6. Jungbunzlauer
            17.1.6.1. Overview
            17.1.6.2. Product Portfolio
            17.1.6.3. Profitability by Market Segments
            17.1.6.4. Sales Footprint
            17.1.6.5. Strategy Overview
                17.1.6.5.1. Marketing Strategy
                17.1.6.5.2. Product Strategy
                17.1.6.5.3. Channel Strategy
        17.1.7. Shandong Fuyuan Bio-Tech CO.LTD.
            17.1.7.1. Overview
            17.1.7.2. Product Portfolio
            17.1.7.3. Profitability by Market Segments
            17.1.7.4. Sales Footprint
            17.1.7.5. Strategy Overview
                17.1.7.5.1. Marketing Strategy
                17.1.7.5.2. Product Strategy
                17.1.7.5.3. Channel Strategy
        17.1.8. Roquette Frères
            17.1.8.1. Overview
            17.1.8.2. Product Portfolio
            17.1.8.3. Profitability by Market Segments
            17.1.8.4. Sales Footprint
            17.1.8.5. Strategy Overview
                17.1.8.5.1. Marketing Strategy
                17.1.8.5.2. Product Strategy
                17.1.8.5.3. Channel Strategy
        17.1.9. Shandong Xinhong Pharmaceutical Co., Ltd.
            17.1.9.1. Overview
            17.1.9.2. Product Portfolio
            17.1.9.3. Profitability by Market Segments
            17.1.9.4. Sales Footprint
            17.1.9.5. Strategy Overview
                17.1.9.5.1. Marketing Strategy
                17.1.9.5.2. Product Strategy
                17.1.9.5.3. Channel Strategy
        17.1.10. Shandong Baisheng Biotechnology Co., Ltd.
            17.1.10.1. Overview
            17.1.10.2. Product Portfolio
            17.1.10.3. Profitability by Market Segments
            17.1.10.4. Sales Footprint
            17.1.10.5. Strategy Overview
                17.1.10.5.1. Marketing Strategy
                17.1.10.5.2. Product Strategy
                17.1.10.5.3. Channel Strategy
        17.1.11. Ceto Coorporation
            17.1.11.1. Overview
            17.1.11.2. Product Portfolio
            17.1.11.3. Profitability by Market Segments
            17.1.11.4. Sales Footprint
            17.1.11.5. Strategy Overview
                17.1.11.5.1. Marketing Strategy
                17.1.11.5.2. Product Strategy
                17.1.11.5.3. Channel Strategy
        17.1.12. Creative Compound
            17.1.12.1. Overview
            17.1.12.2. Product Portfolio
            17.1.12.3. Profitability by Market Segments
            17.1.12.4. Sales Footprint
            17.1.12.5. Strategy Overview
                17.1.12.5.1. Marketing Strategy
                17.1.12.5.2. Product Strategy
                17.1.12.5.3. Channel Strategy
        17.1.13. Foodchem International
            17.1.13.1. Overview
            17.1.13.2. Product Portfolio
            17.1.13.3. Profitability by Market Segments
            17.1.13.4. Sales Footprint
            17.1.13.5. Strategy Overview
                17.1.13.5.1. Marketing Strategy
                17.1.13.5.2. Product Strategy
                17.1.13.5.3. Channel Strategy
        17.1.14. Merck Millipore
            17.1.14.1. Overview
            17.1.14.2. Product Portfolio
            17.1.14.3. Profitability by Market Segments
            17.1.14.4. Sales Footprint
            17.1.14.5. Strategy Overview
                17.1.14.5.1. Marketing Strategy
                17.1.14.5.2. Product Strategy
                17.1.14.5.3. Channel Strategy
18. Assumptions & Acronyms Used
19. Research Methodology
Recommendations

Food and Beverage

Food Premix Market

March 2024

REP-GB-895

350 pages

Food and Beverage

Bakery Ingredient Market

October 2023

REP-GB-416

339 pages

Explore Food and Beverage Insights

View Reports
Future Market Insights

Glucuronolactone Market

Schedule a Call